TSP50 attenuates metabolic dysfunction-associated steatotic liver disease via SCD1 degradation-mediated suppression of hepatocyte lipogenesis.

ABSTRACT:

SUBMITTER: Liang J 

PROVIDER: S-EPMC12874672 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature